We propose to create a predoctoral training program in nanotechnology for cancer medicine - The Johns Hopkins Cancer Nanotechnology Training Center (CNTC) - that will be positioned at the interface of cancer biology and nanotechnology and will establish a unique national resource with interdisciplinary and synergistic programs in both fundamental and translational research in cancer medicine. The CNTC will foster predoctoral fellows who will be trained across disciplines to lay foundations for technologies that will enable an inside-view of cancer cell functions as opposed to the limited black-box input-output techniques currently used, introduce new modalities for molecular imaging, develop new high-throughput diagnostic tools, and engineer novel viral and non-viral delivery systems to treat human cancers. CNTC fellows will view interactions between nanostructures and biological systems in physical, biological, and biomedical terms and will become adept at emerging concepts in biomolecular engineering, protein engineering, materials synthesis and surface modification, which are required to create nanotechnology to elucidate and monitor in real-time signaling pathways that lead to cancer transformation. CNTC fellows will also develop novel cancer diagnostics to evaluate each individual patient's prognosis and optimal treatment, based upon the patients'genetic and epigenetic markers and disease phenotype and therapeutics that are selected and optimized for each individual patient. The CNTC will train a cadre of predoctoral fellows for a future in research in academia and research laboratories in industry. Through independent proposal writing, the CNTC will emphasize early independence in research. CNTC fellows will be able to take advantage of research and clinical resources at the Johns Hopkins Hospital, the NCI- designated Sidney Kimmel Comprehensive Cancer Center, the Ludwick Center for Cancer Genetics and Therapeutics, The Sol Goldman Pancreatic Cancer Center, the In Vivo Cellular and Molecular Imaging Center, and the Johns Hopkins Engineering in Oncology Center PSOC as well as the unique educational resources and experimental facilities of the Johns Hopkins Institute for NanoBioTechnology, where the CNTC will be administratively housed.
to Public Health. The proposed predoctoral training program will train fellows at the interface between nanotechnology and cancer medicine to develop novel nanoscale therapeutic and diagnostic tools for the detection, treatment and cure of human cancer.
|Kosmides, A K; Meyer, R A; Hickey, J W et al. (2017) Biomimetic biodegradable artificial antigen presenting cells synergize with PD-1 blockade to treat melanoma. Biomaterials 118:16-26|
|Roman, Jose A; Reucroft, Ian; Martin, Russell A et al. (2016) Local Release of Paclitaxel from Aligned, Electrospun Microfibers Promotes Axonal Extension. Adv Healthc Mater 5:2628-2635|
|Mangraviti, Antonella; Tzeng, Stephany Y; Gullotti, David et al. (2016) Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival. Biomaterials 100:53-66|
|Meyer, Randall A; Green, Jordan J (2016) Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle design. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:191-207|
|Kozielski, Kristen L; Green, Jordan J (2016) Bioreducible Poly(Beta-Amino Ester)s for Intracellular Delivery of SiRNA. Methods Mol Biol 1364:79-87|
|Meyer, Randall A; Sunshine, Joel C; Perica, Karlo et al. (2015) Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation. Small 11:1519-25|
|Meyer, Randall A; Meyer, Randall S; Green, Jordan J (2015) An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles. J Biomed Mater Res A 103:2747-57|
|Meyer, Randall A; Green, Jordan J (2015) Biodegradable polymer iron oxide nanocomposites: the future of biocompatible magnetism. Nanomedicine (Lond) 10:3421-5|
|Bishop, Corey J; Kozielski, Kristen L; Green, Jordan J (2015) Exploring the role of polymer structure on intracellular nucleic acid delivery via polymeric nanoparticles. J Control Release 219:488-499|
|Meyer, Randall A; Sunshine, Joel C; Green, Jordan J (2015) Biomimetic particles as therapeutics. Trends Biotechnol 33:514-524|
Showing the most recent 10 out of 25 publications